A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of Extended Release
Osmotic Controlled-Release Oral Delivery System (OROS) Paliperidone compared to placebo in
patients with Schizophrenia. Olanzapine will be used as a reference drug in the study.